Dividend Aristocrats lag the S&P 500 in 2025, but payout growth stays strong and 21 stocks show 10%+ return potential. Find ...

We favor dividend growth over high yield, spotlighting 3 undervalued, fast-growing, investment-grade stocks with 10–16% ...

Ares Capital stands out with low leverage, strong liquidity and solid dividends. Click to read more on why ARCC is a 'hold' ...

Realty Income offers a reliable, growing monthly dividend, backed by a strong credit rating. Click here to read more about O ...

Medtronic's margin inflection from the Diabetes spin-off and strong innovation pipeline support major upside. Find out why ...

AVL offers 2x daily exposure to AVGO, ideal for short-term trades on catalysts like earnings, but comes with high risk due to ...

Vale trades at a steep discount to peers despite strong fundamentals, global reach, and improving diversification. Find out ...

Micron’s Data Center growth, strong Q3 results, and upbeat Q4 guidance highlight AI momentum and margin gains despite rising ...

ZAG:CA from BMO offers a mix of investment grade government and corporate bonds, appealing to conservative fixed-income ...

Teekay management signals uncertainty as bearish indicators rise, making cash-raising strategies wiser than buying dips. Find ...

Bristol-Myers Squibb faces patent losses and growth headwinds despite pipeline gains, debt cuts, and dividends. Read why BMY ...

Oscar Health posted strong Q1 results with rising margins, tech efficiencies, and major upside supported by DCF valuation.